Literature DB >> 7878523

The eye and the eosinophil.

S D Trocme1, A J Aldave.   

Abstract

Recent work has highlighted the eosinophil's role as an effector cell in a wide array of disease entities, including parasitic infections and allergic and nonallergic diseases. The eosinophil is filled with granules containing toxic cationic proteins, capable of harming tissue when released to the extracellular space. In the eye, toxic eosinophil cationic granule proteins have been encountered in conjunctiva, cornea, tears, and contact lenses of patients suffering from ocular allergy, suggesting an effector role for the eosinophil in the ophthalmic manifestations of atopy. Laboratory investigations indicate that eosinophil granule major basic protein, the principal eosinophil granule protein, may adversely influence corneal epithelium, and promote corneal ulceration in the severest forms of ocular allergy. Further, the eosinophil may play a contributory pathophysiologic role in some nonallergic ophthalmic diseases such as Wegener's granulomatosis, orbital pseudo-tumor, and histiocytosis X. The eosinophil's morphologic, immunologic, and biochemical characteristics will be reviewed and its role in certain ophthalmic diseases thoroughly examined.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7878523     DOI: 10.1016/0039-6257(94)90197-x

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  11 in total

1.  Effect of lodoxamide and disodium cromoglycate on tear eosinophil cationic protein in vernal keratoconjunctivitis.

Authors:  A Leonardi; F Borghesan; A Avarello; M Plebani; A G Secchi
Journal:  Br J Ophthalmol       Date:  1997-01       Impact factor: 4.638

2.  Eosinophil granule proteins expressed in ocular cicatricial pemphigoid.

Authors:  A Heiligenhaus; J Schaller; S Mauss; S Engelbrecht; J E Dutt; C S Foster; K P Steuhl
Journal:  Br J Ophthalmol       Date:  1998-03       Impact factor: 4.638

Review 3.  Host immune cellular reactions in corneal neovascularization.

Authors:  Nizar S Abdelfattah; Mohamed Amgad; Amira A Zayed
Journal:  Int J Ophthalmol       Date:  2016-04-18       Impact factor: 1.779

4.  Presumed ocular larva migrans presenting with features of diffuse unilateral subacute neuroretinitis.

Authors:  F B Kinnear; J Hay; G N Dutton; H V Smith
Journal:  Br J Ophthalmol       Date:  1995-12       Impact factor: 4.638

5.  Candida endophthalmitis.

Authors:  H M Towler; S Lightman; M Matheson
Journal:  Br J Ophthalmol       Date:  1995-12       Impact factor: 4.638

6.  Toll-like receptor 4 signalling attenuates experimental allergic conjunctivitis.

Authors:  S-H Chung; S H Choi; K J Cho; C-K Joo
Journal:  Clin Exp Immunol       Date:  2011-03-10       Impact factor: 4.330

Review 7.  Immune Cells in Subretinal Wound Healing and Fibrosis.

Authors:  Manon Szczepan; María Llorián-Salvador; Mei Chen; Heping Xu
Journal:  Front Cell Neurosci       Date:  2022-06-10       Impact factor: 6.147

8.  Th1- and Th2-type cytokines in chronic ocular allergy.

Authors:  Andrea Leonardi; Iva A Fregona; Mario Plebani; Antonio G Secchi; Virginia L Calder
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-03-15       Impact factor: 3.117

9.  Clinical and biological efficacy of preservative-free NAAGA eye-drops versus levocabastine eye-drops in vernal keratoconjunctivitis patients.

Authors:  A Leonardi; D Bremond-Gignac; M Bortolotti; D Violato; P Pouliquen; L Delval; J M Grouin; I A Fregona
Journal:  Br J Ophthalmol       Date:  2007-06-21       Impact factor: 4.638

10.  Interleukin 4 and T helper type 2 cells are required for development of experimental onchocercal keratitis (river blindness).

Authors:  E Pearlman; J H Lass; D S Bardenstein; M Kopf; F E Hazlett; E Diaconu; J W Kazura
Journal:  J Exp Med       Date:  1995-10-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.